CORELEADER HEMO-PAD MODEL CPII 02030— 510(k) K102944

Name: FDA 510(k) clearance K102944
Creator: U.S. Food and Drug Administration
Published: 2011-09-07

Substantially Equivalent

Coreleader Biotech Co., Ltd.

FDA 510(k) clearance K102944 for CORELEADER HEMO-PAD MODEL CPII 02030, Substantially Equivalent on 2011-09-07. Applicant: Coreleader Biotech Co., Ltd.. Device class: Unclassified.

Clearance details

Applicant: Coreleader Biotech Co., Ltd.
Product code: Code QSY
Device class: Unclassified
Advisory panel: Unknown
Date received: 2010-10-04
Decision date: 2011-09-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Taipei, Taiwan, TW

Download summary PDF View on FDA.gov ↗

Recent devices under product code QSY

view all

K253017 — BloodSTOP iX Trauma Matrix (TM-iX-20)2026-04-30
K251700 — Ganymede 2cm diameter (FG100300) +14 more2026-02-26
K250319 — MFUSE (MS001)2025-12-15
K253609 — TRAUMAGEL® 2.0 Hemostatic Gel2025-12-12
K240713 — TRAUMAGEL®2024-08-14

More clearances from Coreleader Biotech Co., Ltd.

view all

K151204 — HEMO-Bandage2015-07-31
K141382 — BIOS KING BIOCELLULOSE FILM2015-02-10
K123394 — CORELEADER HYDRO-HEALER HYDROCOLLOID WOUND DRESSING2013-06-06
K111578 — CORELEADER COLLA-ALGI FIBER MODEL CAW2011-09-23
K111733 — CORELEADER SCAR-DIMMER2011-09-22

Adverse events under product code QSY

product code QSY

Death: 5
Other: 1
Total: 6

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.